Subscribe or Manage Preferences
View Latest Issue
Washington, DC—Researchers have customized a software suite to automatically determine the disease severity in patients with rheumatoid arthritis (RA) based on information from their electronic medical records (EMRs). This is a solid first step toward streamlining and individualizing diagnosis and treatment of this condition, according to the investigators.
As healthcare reform continues to unfold, an increasing amount of pressure is being placed on payers, providers, and patients to address the rising cost of care. Greater attention is being paid to patients with inflammatory arthritis and other autoimmune conditions treated with chronic biologic therapies.
Charlotte, NC—At the end of the North Carolina Rheumatology Association (NCRA) annual meeting, Shane Anderson, MD, President of the Association discussed the meeting, challenges he faces in his practice as well as his thoughts on ICD-10. Dr Anderson is a Practicing Rheumatologist in Greensboro, North Carolina, and has been the president of the association for the past 2 years.
Whistler, BC—Rituximab plus methotrexate is well tolerated in patients with moderate-to-severe, active rheumatoid arthritis (RA) who take the medications for up to 11 years, according to recent research.
The total fixed costs of treating patients with rheumatoid arthritis (RA) in Sweden increased by 32% between 1990 and 2010, years that encompass the time period when biologic therapies became available. These results of a large, population-based registry study suggest that hospitalization and other indirect costs associated with RA have not been reduced enough to offset the increased cost of more expensive drugs.
Value Propositions from the April 2014 issue.
Vancouver, British Columbia—A study of 143 men with hematospermia revealed that approximately 15% also had hyperuricemia.
Charlotte, NC—How many rheumatologists can say they can cure gout? Not many can confidently say so, according to an informal poll taken during the 2014 North Carolina Rheumatology Association annual meeting.
A previously unknown locus for rheumatoid arthritis (RA) susceptibility has been identified by researchers from the United Kingdom involved in the genome-wide association studies (GWAS), according to a recent study.
A newly developed plasma cell (PC) 5-gene signature accurately measures PC levels in patients with scleroderma and other autoimmune diseases, including lupus and rheumatoid arthritis (RA).
Page 1 of 3
Results 1 - 10 of 28
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology